299 related articles for article (PubMed ID: 18757438)
21. Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.
Ungefroren H; Gieseler F; Kaufmann R; Settmacher U; Lehnert H; Rauch BH
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29795022
[TBL] [Abstract][Full Text] [Related]
22. PAR1- and PAR2-induced innate immune markers are negatively regulated by PI3K/Akt signaling pathway in oral keratinocytes.
Rohani MG; DiJulio DH; An JY; Hacker BM; Dale BA; Chung WO
BMC Immunol; 2010 Oct; 11():53. PubMed ID: 21029417
[TBL] [Abstract][Full Text] [Related]
23. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.
Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L
J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479
[TBL] [Abstract][Full Text] [Related]
24. Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.
Yoon H; Radulovic M; Wu J; Blaber SI; Blaber M; Fehlings MG; Scarisbrick IA
J Neurochem; 2013 Oct; 127(2):283-98. PubMed ID: 23647384
[TBL] [Abstract][Full Text] [Related]
25. Modulation of expression of innate immunity markers CXCL5/ENA-78 and CCL20/MIP3alpha by protease-activated receptors (PARs) in human gingival epithelial cells.
Rohani MG; Beyer RP; Hacker BM; Dommisch H; Dale BA; Chung WO
Innate Immun; 2010 Apr; 16(2):104-14. PubMed ID: 19567485
[TBL] [Abstract][Full Text] [Related]
26. The transient receptor potential vanilloid 4 (TRPV4) ion channel mediates protease activated receptor 1 (PAR1)-induced vascular hyperpermeability.
Peng S; Grace MS; Gondin AB; Retamal JS; Dill L; Darby W; Bunnett NW; Abogadie FC; Carbone SE; Tigani T; Davis TP; Poole DP; Veldhuis NA; McIntyre P
Lab Invest; 2020 Aug; 100(8):1057-1067. PubMed ID: 32341518
[TBL] [Abstract][Full Text] [Related]
27. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
[TBL] [Abstract][Full Text] [Related]
28. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
[TBL] [Abstract][Full Text] [Related]
29. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells.
Riewald M; Petrovan RJ; Donner A; Ruf W
J Endotoxin Res; 2003; 9(5):317-21. PubMed ID: 14577849
[TBL] [Abstract][Full Text] [Related]
30. PAR
Grisaru-Granovsky S; Kumar Nag J; Zakar L; Rudina T; Lal Gupta C; Maoz M; Kozlova D; Bar-Shavit R
FASEB J; 2020 Dec; 34(12):15701-15717. PubMed ID: 33136328
[TBL] [Abstract][Full Text] [Related]
31. Distinct roles for PAR1- and PAR2-mediated vasomotor modulation in human arterial and venous conduits.
Ballerio R; Brambilla M; Colnago D; Parolari A; Agrifoglio M; Camera M; Tremoli E; Mussoni L
J Thromb Haemost; 2007 Jan; 5(1):174-80. PubMed ID: 17059415
[TBL] [Abstract][Full Text] [Related]
32. Protease-activated receptor (PAR)1, PAR2 and PAR4 expressions in esophageal squamous cell carcinoma.
Li SM; Jiang P; Xiang Y; Wang WW; Zhu YC; Feng WY; Li SD; Yu GY
Dongwuxue Yanjiu; 2014 Sep; 35(5):420-5. PubMed ID: 25297082
[TBL] [Abstract][Full Text] [Related]
33. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: role in factor Xa signaling.
Feistritzer C; Lenta R; Riewald M
J Thromb Haemost; 2005 Dec; 3(12):2798-805. PubMed ID: 16359518
[TBL] [Abstract][Full Text] [Related]
34. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells.
Camerer E; Kataoka H; Kahn M; Lease K; Coughlin SR
J Biol Chem; 2002 May; 277(18):16081-7. PubMed ID: 11850418
[TBL] [Abstract][Full Text] [Related]
35. The differential expression of protease activated receptors contributes to functional differences between dark and fair keratinocytes.
Xue M; Lin H; Zhao R; Liang HP; Jackson C
J Dermatol Sci; 2017 Mar; 85(3):178-185. PubMed ID: 27979585
[TBL] [Abstract][Full Text] [Related]
36. PH motifs in PAR1&2 endow breast cancer growth.
Kancharla A; Maoz M; Jaber M; Agranovich D; Peretz T; Grisaru-Granovsky S; Uziely B; Bar-Shavit R
Nat Commun; 2015 Nov; 6():8853. PubMed ID: 26600192
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor (PAR)2, but not PAR1, is involved in collateral formation and anti-inflammatory monocyte polarization in a mouse hind limb ischemia model.
van den Hengel LG; Hellingman AA; Nossent AY; van Oeveren-Rietdijk AM; de Vries MR; Spek CA; van Zonneveld AJ; Reitsma PH; Hamming JF; de Boer HC; Versteeg HH; Quax PH
PLoS One; 2013; 8(4):e61923. PubMed ID: 23637930
[TBL] [Abstract][Full Text] [Related]
38. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
39. Optical biosensor differentiates signaling of endogenous PAR1 and PAR2 in A431 cells.
Fang Y; Ferrie AM
BMC Cell Biol; 2007 Jun; 8():24. PubMed ID: 17587449
[TBL] [Abstract][Full Text] [Related]
40. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
